Incorporation of the Tat cell-penetrating peptide into nanofibers improves the respective antitumor immune response.

Journal of Cellular Physiology
Mohsen MohammadiKhashayar Hesamizadeh

Abstract

A major challenge for the development of anticancer vaccines is the induction of a safe and effective immune response, particularly mediated by CD8+ T lymphocytes, in an adjuvant-free manner. In this respect, we present a simple strategy to improve the specific CD8+ T cell responses using KFE8 nanofibers bearing a Class I (Kb)-restricted peptide epitope (called E. nanofibers) without the use of adjuvant. We demonstrate that incorporation of Tat, a cell-penetrating peptide (CPP) of the HIV transactivator protein, into E. nanofibers remarkably enhanced tumor-specific CD8+ T cell responses. E. nanofibers containing 12.5% Tat peptide (E.Tat12.5 nanofiber) increased antigen cross-presentation by bone marrow-derived dendritic cells as compared with E. nanofibers, or E. nanofibers containing 25 or 50% the Tat peptide. Uptake of KFE8.Tat12.5 nanofibers by dendritic cells (DCs) was significantly increased compared with KFE8 nanofiber lacking Tat. Peritoneal and lymph node DCs of mice immunized with E.Tat12.5 nanofibers exhibited increased presentation of the H2kb-epitope (reminiscent for cross-presentation) compared with DCs obtained from E. nanofiber vaccinated mice. Tetrameric and intracellular cytokine staining revealed that vaccinat...Continue Reading

References

Aug 3, 2007·Expert Review of Vaccines·Martijn S BijkerSjoerd H van der Burg
Oct 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Martijn S BijkerSjoerd H van der Burg
Oct 28, 2008·Biological Chemistry·Gary T Jennings, Martin F Bachmann
Nov 19, 2008·Japanese Journal of Clinical Oncology·Kyogo ItohMasanori Noguchi
Nov 17, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephen A KabaDavid E Lanar
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jai S RudraJoel H Collier
Mar 31, 2010·PloS One·Alain C TissotMartin F Bachmann
Jan 26, 2012·ACS Nano·Jai S RudraJoel H Collier
Jan 10, 2013·Annual Review of Immunology·Janice S BlumPeter Cresswell
May 18, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Joan T Merrill
May 28, 2013·Seminars in Immunology·Ramon ArensCornelis J M Melief
Jun 12, 2013·PLoS Computational Biology·Christian P KochGisbert Schneider
Jan 1, 2012·Pharmaceuticals·Alfredo Erazo-OliverasJean-Philippe Pellois
Dec 7, 2013·Vaccine·Charles B ChessonJai S Rudra
Jun 14, 2014·Advanced Healthcare Materials·Rebecca R PompanoAnita S Chong
Jun 24, 2014·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Agnieszka Pierzyńska-MachJurek W Dobrucki
Dec 21, 2014·The AAPS Journal·Amanda TrentMatthew V Tirrell
Jan 4, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Kleanthis FytianosBarbara Rothen-Rutishauser
Apr 23, 2015·Nature·Sebastian KreiterUgur Sahin
Jul 15, 2015·Chemical Reviews·Darrell J IrvineTalar Tokatlian
Oct 17, 2015·Bioconjugate Chemistry·Mazda Rad-MalekshahiEnrico Mastrobattista
Nov 13, 2015·Chembiochem : a European Journal of Chemical Biology·Hiroko YamashitaYosuke Demizu
Dec 15, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Catherine A FromenJoseph M DeSimone
Mar 12, 2016·Nature Reviews. Cancer·Sjoerd H van der BurgCornelis J M Melief
May 4, 2016·Cold Spring Harbor Protocols·Urška RepnikBoris Turk
Jan 17, 2017·Molecular Pharmaceutics·Mazda Rad-MalekshahiMaryam Amidi
Feb 18, 2017·Trends in Pharmacological Sciences·Giulia GuidottiDaniela Rossi
Oct 6, 2017·Biomaterials·Carolina Mora-SolanoJoel H Collier
Feb 2, 2018·Science Translational Medicine·Idit Sagiv-BarfiRonald Levy
Mar 7, 2018·Nature Materials·Aileen Weiwei LiDavid J Mooney
Apr 21, 2018·Journal of Controlled Release : Official Journal of the Controlled Release Society·Youhui SiJoel H Collier

❮ Previous
Next ❯

Citations

May 20, 2021·Acta Biomaterialia·Conor L O'NeillJai S Rudra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.